Skip to main content

Advertisement

Table 5 Cultivation and enumeration of Lactococcus lactis in cecal mucosa and stool of Clostridium difficile -infected hamsters

From: The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model

Group (n = 8 each) L. lactisin cecal mucosa L. lactisfrom stool (106CFU/g)  
  (104CFU/g) Day 7 Day 14
Control group 0.413 ± 0.1 Fungi*  
Empty plasmid group 104.75 ± 8.41 ab 109 ± 6.95 e 69.38 ± 6.44dc
Secreted-protein plasmid group 108.25 ± 4.57 ab 124.63 ± 7.92 e 64.38 ± 6.37dc
Membrane-anchored plasmid group 105 ± 3.9 ab 104 ± 3.45 e 53.75 ± 4.30dc
  1. a compared with control group (F=96.289, P=0.000); b compared among immunization groups (F=0.107, P=0.899); e compared among immunization groups (F=0.690, P=0.513); d compared among immunization groups (F=1.9, P=0.174); and c compared between days 7 and 14, P < 0.01. * Grade III dysbacteriosis – appearance of opportunistic flora on top of hemolytic and lactose-negative escherichia, growth of cocci and suppression of lacto- and bifidobacteria (Ladodo scale).